Telehealth

With its strategic pivot to high-growth Med Tech paying off, all eyes are on AngioDynamics' CEO presentation at the upcoming Leerink healthcare conference.

Amid a surge in MedTech M&A, Piper Sandler appoints 25-year veteran Aamer Naseer to steer its life sciences outsourcing and B2B technology groups.

A new partnership between Sibel Health and LookDeep Health combines continuous vitals with bedside AI, aiming to ease staff shortages and improve safety.

As teen mental health struggles soar, experts offer a new playbook for parents, blending virtual care with timeless advice on connection and support.

A landmark partnership aims to bring precision cancer therapy, or Theranostics, to millions in underserved nations, backed by a major WHO resolution.

With new backing from One Six 8 Ventures, health tech firm Respiree accelerates its US and Canadian expansion of its FDA-cleared AI platform.

A new strategic investment in My Pediatric Doctor aims to give families on-demand virtual access to pediatricians, tackling a growing need for care.

A new study confirms Theranica's migraine wearable won't disrupt glucose monitors, a major breakthrough for 4.5 million Americans with both conditions.

A new report offers cities a framework to fight climate change, housing unaffordability, and economic inequity with integrated, equitable strategies.

A new report on 1,800+ patients reveals a model for obesity care that preserves muscle, sustains weight loss, and may solve the GLP-1 cost crisis.

As Autolus heads to key investor conferences, its strong AUCATZYL® sales and deep pipeline face scrutiny against mounting losses and a curious PR misstep.

Tired of juggling multiple health portals? Pixel Health's new AI-powered platform, One Thread, aims to unify the patient journey into a single experience.

The company's revenue skyrocketed, but SEC filings reveal a story of significant liquidity risks and a bold gamble on the booming wellness market.

A Korean firm says it can cure 34 diseases using cells from cloned embryos, walking a fine line between a medical breakthrough and a bioethical taboo.

As Lyell presents at three major investor conferences, the biotech's pipeline, financial health, and future in cancer therapy are under scrutiny.

A Malaysian biotech's new study shows its NK cell therapy is safe, using a novel, low-cost method that could make advanced cancer treatment affordable worldwide.

A new study reveals adults with IDD are 9x more likely to have anxiety or depression, yet face immense barriers to care. This is a systemic failure.

Telehealth firm MangoRx reports explosive growth with its $99/month TRT program, challenging competitors and raising questions about the future of virtual care.

A national provider's acquisition of a New Mexico leader promises to blend technology, research, and capital to reshape autism therapy in underserved regions.

Mayo Clinic implements Dock Health's platform to automate workflows, reduce clinician burden, and ensure patient care plans don't fall through the cracks.